2015
DOI: 10.1007/s13224-015-0718-5
|View full text |Cite
|
Sign up to set email alerts
|

Has Noninvasive Prenatal Testing (NIPT) Come of Age?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 21 publications
(45 reference statements)
0
3
0
Order By: Relevance
“…In January 2015, HUS was the first public hospital in Finland to implement non-invasive prenatal testing (NIPT) as an alternative further testing method to chorionic villus sampling (CVS) and amniocentesis. NIPT is based on next-generation cell-free DNA sequencing in maternal plasma to assess the most common fetal aneuploidies (Allahbadia et al, 2015;Kellogg et al, 2014). As NIPT uses blood samples, pregnancy loss is not a risk (compared to CVS and amniocentesis).…”
Section: Resultsmentioning
confidence: 99%
“…In January 2015, HUS was the first public hospital in Finland to implement non-invasive prenatal testing (NIPT) as an alternative further testing method to chorionic villus sampling (CVS) and amniocentesis. NIPT is based on next-generation cell-free DNA sequencing in maternal plasma to assess the most common fetal aneuploidies (Allahbadia et al, 2015;Kellogg et al, 2014). As NIPT uses blood samples, pregnancy loss is not a risk (compared to CVS and amniocentesis).…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, NIPT, which is based on next-generation sequencing of cell-free fetal DNA in maternal plasma to assess the most common fetal aneuploidies, only uses maternal blood samples [6]. The weakness of NIPT is its false positive rates, which, although very small, require confirmation of the result by invasive procedures [7]. …”
Section: Introductionmentioning
confidence: 99%
“…Amniocentesis and CVS provide an accurate diagnosis but carry a miscarriage risk . In contrast, NIPT, which is based on the next‐generation sequencing of cell‐free DNA in maternal plasma to assess the most common fetal aneuploidies, only uses blood samples and thus largely reduces the risk of pregnancy loss . However, because of NIPT's false positive rates, NIPT is not a diagnostic test but an advanced screening test provided as an option with non‐absolute advantages in prenatal screening and testing paradigm .…”
Section: Introductionmentioning
confidence: 99%